87 related articles for article (PubMed ID: 10519296)
1. Production of plasminogen activator by alveolar macrophages in experimental Pneumocystis carinii pneumonia.
Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
J Eukaryot Microbiol; 1999; 46(5):149S. PubMed ID: 10519296
[No Abstract] [Full Text] [Related]
2. Alterations in surfactant protein A form and clearance during Pneumocystis pneumonia.
Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
J Eukaryot Microbiol; 2006; 53 Suppl 1():S119-21. PubMed ID: 17169024
[No Abstract] [Full Text] [Related]
3. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages.
Limper AH; Crouch EC; O'Riordan DM; Chang D; Vuk-Pavlovic Z; Standing JE; Kwon KY; Adlakha A
J Lab Clin Med; 1995 Nov; 126(5):416-22. PubMed ID: 7595025
[No Abstract] [Full Text] [Related]
4. Surfactant protein binding to Pneumocystis carinii organisms.
Pottratz ST
J Lab Clin Med; 1995 Nov; 126(5):414-5. PubMed ID: 7595024
[No Abstract] [Full Text] [Related]
5. Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumonia.
Liao CP; Lasbury ME; Wang SH; Zhang C; Durant PJ; Tschang D; Lee CH
J Eukaryot Microbiol; 2006; 53 Suppl 1():S134-5. PubMed ID: 17169031
[No Abstract] [Full Text] [Related]
6. Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia.
Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
Microbiol Immunol; 2001; 45(8):605-11. PubMed ID: 11592634
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia.
Ray CA; Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
J Eukaryot Microbiol; 2006; 53 Suppl 1():S127-9. PubMed ID: 17169028
[No Abstract] [Full Text] [Related]
8. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients.
Angelici E; Contini C; Romani R; Epifano O; Serra P; Canipari R
AIDS; 1996 Mar; 10(3):283-90. PubMed ID: 8882668
[TBL] [Abstract][Full Text] [Related]
9. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
[TBL] [Abstract][Full Text] [Related]
10. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia.
Limper AH; O'Riordan DM; Vuk-Pavlovic Z; Crouch EC
J Eukaryot Microbiol; 1994; 41(5):98S. PubMed ID: 7804292
[No Abstract] [Full Text] [Related]
12. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
[TBL] [Abstract][Full Text] [Related]
13. Alveolar response to experimental Pneumocystis carinii pneumonia in the rat.
Lanken PN; Minda M; Pietra GG; Fishman AP
Am J Pathol; 1980 Jun; 99(3):561-88. PubMed ID: 6966893
[TBL] [Abstract][Full Text] [Related]
14. Recovery from Pneumocystis carinii pneumonia in dexamethasone-treated Wistar rats.
Sukura A; Konttinen YT; Sepper R; Lindberg LA
Eur Respir J; 1995 May; 8(5):701-8. PubMed ID: 7656938
[TBL] [Abstract][Full Text] [Related]
15. [Study on inflammatory response and alteration of biochemical components in BALF from Pneumocystis carinii pneumonia].
Rong Z; He L; Qu J
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Sep; 22(9):548-51. PubMed ID: 11776769
[TBL] [Abstract][Full Text] [Related]
16. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.
Lasbury ME; Lin P; Tschang D; Durant PJ; Lee CH
Infect Immun; 2004 Apr; 72(4):2140-7. PubMed ID: 15039336
[TBL] [Abstract][Full Text] [Related]
17. Expression and activation of complement protein and alveolar damage during Pneumocystis pneumonia.
Lasbury ME; Durant PJ; Tschang D; Wang SH; Zhang C; Liao CP; Lee CH
J Eukaryot Microbiol; 2006; 53 Suppl 1():S136-7. PubMed ID: 17169032
[No Abstract] [Full Text] [Related]
18. Changes in alveolar macrophage number are early events in Pneumocystis carinii infection.
Lasbury ME; Durant PJ; Lee CH
J Eukaryot Microbiol; 2001; Suppl():161S-162S. PubMed ID: 11906044
[No Abstract] [Full Text] [Related]
19. Bronchoalveolar lavage fluid from Pneumocystis carinii-infected rats inhibits phagocytosis in normal alveolar macrophages.
Lasbury ME; Durant PJ; Lee CH
J Eukaryot Microbiol; 2001; Suppl():163S-164S. PubMed ID: 11906045
[No Abstract] [Full Text] [Related]
20. GM-CSF expression in the lung during Pneumocystis pneumonia.
Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
J Eukaryot Microbiol; 2006; 53 Suppl 1():S124-6. PubMed ID: 17169027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
